Calcifediol: clinical experience in geriatric patients with type 2 diabetes

Czech version

Authors: Zbynek Schroner
Authors‘ workplace: Lekárska fakulta, Univerzita Pavla Jozefa Šafárika v Košiciach ; Lekárska fakulta, Univerzita Pavla Jozefa Šafárika v Košiciach
Published in: Diab Obez 2026; 26(1): 53-55
Category: News

Sources

Roth DE , Abrams SA, Aloia E et al. Global prevalence and disease burden of vitamin D deficiency: a roadmap for action in low -⁠ and middle-income countries. Ann NY Acad Sci 2018; 1430(1): 44–79. Dostupné z DOI: <http://dx.doi.org/10.1111/nyas.13968>.
Belle TL, Gysemans C, Mathieu CH. Vitamin D and diabetes: the odd couple. Trends Endocrinol Metab 2013; 24(11): 561–568. Dostupné z DOI: <http://dx.doi.org/10.1016/j.tem.2013.07.002>.
Demer LL, Hsu JJ, Tintut Y. Steroid Hormone Vitamin D: Implications for Cardiovascular Disease. Circ Res 2018; 122(11): 1576–1585. Dostupné z DOI: <http://dx.doi.org/10.1161/CIRCRESAHA.118.311585>.
Bouillon R. Comparative analysis of nutritional guidelines for vitamin D. Nat Rev Endocrinol. 2017; 13(8): 466–479. Dostupné z DOI: <http://dx.doi.org/10.1038/nrendo.2017.31>.
Jodar E, Campusano C, de Jong RT et al. Calcifediol: a review of its pharmacological characteristics and clinical use in correcting vitamin D deficiency. Eur J Nutr 2023; 62(4):1579–1597. Dostupné z DOI: <http://dx.doi.org/10.1007/s00394–023–03103–1>.